June 29, 2012 -- Molecular imaging manufacturer IBA Molecular has signed an agreement to install its first Proteus ONE unit in Europe, at Centre Antoine-Lacassagne, in Nice, France.
The agreement is worth 20 million euros ($25 million U.S.) and includes a 10-year service contract, IBA said.
The second-generation proton-beam system includes a pencil-beam scanning nozzle, enabling high-definition conformality to tumors as well as rapid dose delivery. It will complement the existing medium-energy biomedical cyclotron that has been used at the facility since 1991 to treat eye melanomas, IBA said.
IBA secures new radiopharmacy contracts, June 5, 2012
IBA installs cyclotron, proton system in Italy, May 8, 2012
Toshiba debuts new Aquilion LB scanner at ESTRO, May 7, 2012
IBA Molecular deal finalized, April 2, 2012
IBA posts 2011 gains but net loss, March 19, 2012